Third-party lab testing: 3 independent Janoshik assays on file, covering 3 substances, median measured purity 99.8%, most recent test 2026-04-14.
Taishijie is listed as active. Identified through Janoshik third-party lab testing: 3 assays on file, most recent 2026-04-14.
| Substance | Measured purity | Test date |
|---|---|---|
| Ghk-cu 100mg | 99.44% | 2026-04-14 |
| Tirzepatide 20mg | 99.81% | 2026-04-14 |
| Retatrutide 20mg | 99.82% | 2026-04-14 |
| Status | Active |
|---|---|
| Independent assays on file | 3 |
| Median measured purity | 99.8% |
| Certificates of analysis | Vendor states COAs are available |
| Vendor type | Research-use supplier |
| Last tested | 2026-04-14 |
Taishijie is listed as active and we hold 3 independent Janoshik assays on file, median measured purity 99.8%. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. We hold 3 third-party Janoshik assays for Taishijie, covering 3 substances, with a median measured purity of 99.8%. The most recent is dated 2026-04-14.
Tested substances: Ghk-cu 100mg, Tirzepatide 20mg, Retatrutide 20mg.
Similar vendors: PeptiAtlas, Vicopeptide, Taikangbio, Zjpeptix, Cocer Peptides, Eros Peptides, Kensingtonlabs.co, Modern Peptides.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: TCI Peptides Review, TeaHRT Peptides Review, Teyi Peptide Review.